Skip to main content
    T

    The Joint Corp (JYNT)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $6.66
    -0.28 (-4.03%)

    Market Cap: $95.00M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    The Joint Corp (JYNT) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    The Joint (JYNT) trades at 29.0x trailing earnings and 1.6x sales. Its P/S of 1.6x is below its 5-year median of 3.0x. Its forward P/E is 9.7x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 199.0% higher over the next year. Its free cash flow yield is 2.4%.

    MultipleValue
    P/E (trailing)29.0x
    Forward P/E9.7x
    Price to sales1.6x
    Price to book7.6x
    EV/EBITDA15.6x
    Price to FCF41.3x
    EV/FCF33.2x
    PEG8.8
    FCF yield2.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 48.4% below 3.1x and its P/B is 21.6% below 9.7x.

    MultipleCurrent5-year median10-year median
    P/S1.6x3.0x3.1x
    P/B7.6x7.6x9.7x
    Medians of month-end values through Oct 2026: 57 to 60 months (5-year) and 117 to 120 months (10-year).

    Valuation History

    Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 29.2x in 2020 to 166.4x in 2018.

    Year endPriceP/EP/SP/B
    2025$8.7287.2x2.4x8.4x
    2024$10.6360.7x3.0x7.7x
    2023$9.61N/A3.0x5.7x
    2022$13.98127.1x3.8x6.4x
    2021$65.69136.9x11.9x32.4x
    2020$26.2629.2x6.3x18.3x
    2019$16.1470.2x4.7x41.0x
    2018$8.32166.4x3.1x49.7x
    2017$4.96N/A1.3x13.8x
    2016$2.65N/A1.6x4.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About JYNT

    What is JYNT's forward P/E ratio?

    The Joint has a forward P/E ratio of 9.7x.

    Is JYNT stock overvalued?

    GNG's valuation label for JYNT is Undervalued.

    What is JYNT's price to sales ratio?

    The Joint has a price to sales ratio of 1.6x.

    What is JYNT's PEG ratio?

    The Joint has a PEG ratio of 8.8.